| Literature DB >> 31998746 |
Ashirbad Guria1, Priyanka Sharma2, Sankar Natesan2, Gopal Pandi1.
Abstract
Circular RNAs are the most recent addition in the non-coding RNA family, which has started to gain recognition after a decade of obscurity. The first couple of reports that emerged at the beginning of this decade and the amount of evidence that has accumulated thereafter has, however, encouraged RNA researchers to navigate further in the quest for the exploration of circular RNAs. The joining of 5' and 3' ends of RNA molecules through backsplicing forms circular RNAs during co-transcriptional or post-transcriptional processes. These molecules are capable of effectively sponging microRNAs, thereby regulating the cellular processes, as evidenced by numerous animal and plant systems. Preliminary studies have shown that circular RNA has an imperative role in transcriptional regulation and protein translation, and it also has significant therapeutic potential. The high stability of circular RNA is rendered by its closed ends; they are nevertheless prone to degradation by circulating endonucleases in serum or exosomes or by microRNA-mediated cleavage due to their high complementarity. However, the identification of circular RNAs involves diverse methodologies and the delineation of its possible role and mechanism in the regulation of cellular and molecular architecture has provided a new direction for the continuous research into circular RNA. In this review, we discuss the possible mechanism of circular RNA biogenesis, its structure, properties, degradation, and the growing amount of evidence regarding the detection methods and its role in animal and plant systems.Entities:
Keywords: backsplicing; biogenesis; circRNA; long non-coding RNA; miRNA sponging
Year: 2020 PMID: 31998746 PMCID: PMC6965350 DOI: 10.3389/fmolb.2019.00146
Source DB: PubMed Journal: Front Mol Biosci ISSN: 2296-889X
Figure 1Schematic representation of role of cis sequence and trans factor in different models of circRNA biogenesis. Normally, the pre-mRNA is enriched with the exonic and intronic region (I). The non-coding intronic region harbors the highly conserved sequence in the 5′ and 3′, which is essential for splicing by spliceosomal machinery (I). In addition to the conserved sequence, flanking introns consist of a repeat sequence or RBP site, which help to bring the 5′ and 3′ ends of intervening exon closer together due to either the base pairing (IIa, IIc) or by the binding of RBP (IIb, IId). Due to this proximity, circRNAs are generated by exon skipping or direct backsplicing (IIIa, IVa). Exon skipping produces linear RNA first, followed by the circularization of an intervening exon along with the formation of a lariat containing flanking introns (IIIb). Subsequent splicing yields a circular exonic RNA (IVb). In contrast, in direct backsplicing, exonic circRNA is generated first (IIIc, IVc) and is then followed by an exon–intron lariat (IIId). The latter is processed further to convert it into linear RNA (IVd). The pictorial representation is not to scale.
Figure 2Possibilities of circRNA biogenesis during splice site mutation. Canonical splice sites in exon(s) of pre-mRNA (Ia) surrounded by a repeat sequence in flanking introns brings the 5′ and 3′ ends of intervening exons closer (Ib), thereby resulting in the formation of a linear RNA and a circRNA (Ic). However, mutation in the natural splice site of pre-mRNA (IIa, IIIa) allows the spliceosome to access the next cryptic splice site possible, present within either an exon or intron (IIb). Cleavage at the cryptic site results in production of circRNA with a shortened exon and an extended intron before the cryptic site, whereas the leftover exon may remain, along with the exon–intron lariat (IIc). Subsequent splicing of the latter leads to the formation of an exon-skipped linear RNA, followed by the possible degradation of a remnant exon (IId). In another scenario of natural splice-site mutation where the immediate cryptic sites are unavailable, the spliceosome may be more inclined toward the next possible splice site of the exon that is flanked by a repeat sequence (IIIb). This may result in the generation of a new exonic circRNA and an exon-skipped linear RNA with intron retention (IIIc). The pictorial representation is not to scale.
Types of circRNAs.
| Exonic circRNA | e-circRNA | Exon | exon | It can be on the same or multiple exons |
| Intronic circRNA | i-circRNA | Intron | intron | Both sites on the single intron |
| Exon–intron circRNA | ei-circRNA | exon | Intron | 1st splice site on exon and 2nd splice site on intron, may or may not be spanned by the intervening exon or/and intron. |
| Intron–exon circRNA | ie-circRNA | Intron | Intron | On different introns spanned by one or multiple exons |
| UTR circRNA | u-circRNA | UTR | UTR | Both can be on 5′ or 3′ or there can be one at 5′ and one on 3′ |
| UTR-exon circRNA | ue-circRNA | UTR | Exon | circRNA formed at 5′ or 3′ end |
| UTR-intron circRNA | ui-circRNA | UTR | Intron | circRNA formed at 5′ or 3′ end with single or multiple exons in between |
| Intergenic circRNA | ig-circRNA | Intergenic | Intergenic | Both sites on same intergenic region |
| Intergenic-genic circRNA | igg-circRNA | Intergenic | Genic | Genic could be from exon or intron |
| Across genic circRNA | Ag-circRNA | Genic | genic | Sites will be spanned by intergenic region |
Figure 3Pictorial representation of circRNAs with putative secondary imperfect duplex(es). CircRNA with a double-stranded RNA (dsRNA) foldback structure can be made possible by having single (A,B), double (C), or multiple projections (D). Colored parallel lines represent different sizes of complementary regions (dsRNA regions), and black loops represent different sizes of non-complementary regions. The pictorial representation is not to scale.
Figure 4Possible alternate backsplicing and canonical splicing. Presence of cis sequences across introns in pre-mRNA results in formation of circRNAs of varying sizes that are comprised of different exons with or without introns (A–D). Presence of indirect repeat sequence in the same intron causes sequential joining of flanking exons to form linear RNA (E). The pictorial representation does not reflect in actual scale.
Functional characterization of circRNAs and their significance in disease curbing.
| Breast cancer (BC) | Hsa_circ_0004771 | 13 binding sites for different miRNAs | Circinteractome, TargetScan | Xie et al., | |
| Lung adenocarcinoma (LUAD) | CircMTO1 (low)/miR-17 (high)/QKI-5 (low) | CircMTO1 derived from exon 2 and 3 of | RNAhybrid, miRanda, TargetScan | Zhang et al., | |
| Non-small cell lung carcinoma (NSCLC) | CircP4HB (high)/miR-133a-5p (low)/Vimentin (high) | Derived from exon of | Arraystar software | Wang T. et al., | |
| Bladder carcinoma (BCa) | CircDOCK1 (high)/hsa_miR_132-3p (low)/Sox5 (high) | CircDOCK1 has potential binding sites for five different miRNAs | PicTar, TargetScan | Liu P. et al., | |
| CircHIPK3 (low)/miR-558 (high)/HPSE (Heparanase) (high) | Derived from exon 2 of | miRanda, PITA, RNAhybrid | Li et al., | ||
| CircTCF25 (high)/miR-103a-3p and miR-107 (low)/CDK6 (high) | Derived from exon(s) of | miRanda, TargetScan, DIANA-miRPath, DAVID | Zhong et al., | ||
| Hsa_circ_0068871 (high)/miR-181a-5p (low)/FGFR3 (high) | Derived from exon 4–8 of | circBase, CircNet, CircInteractome, TargetScan, RNA 22v2 | Mao et al., | ||
| CircITCH (low)/miR-17, miR-224 (high)/p21, PTEN (low) | Derived from several exons of | Starbase V2.0, Circinteractome | Yang C. et al., | ||
| Hepatocellular carcinomas (HCC) | Cir_0005986 (low)/miR-129-5p (high)/Notch1 (low) | Derived from gene | DIAN mirPath v.3, Arraystar software, miRTarBase | Fu et al., | |
| Laryngeal squamous cell carcinoma (LSCC) | CircRASSF2 (high)/miR-302b-3p (low)/IGF-1R (high) | Derived from | TargetScan, PicTar, miRanda | Tian et al., | |
| Pancreatic ductal adenocarcinoma (PDAC) | CircRNA_100782 (high)/miR-124 (low)/IL-6, STAT3 (high) | Derived from sequence on chromosome 11 | TargetScan | Chen et al., | |
| Gastric cancer (GC) | CircRNA_100269 (low)/miR-630 (high)/LPHN2 (low) | Derived from exon of | TargetScan, miRanda | Zhang Y. et al., | |
| Esophageal squamous cell carcinoma (ESCC) | CircITCH (low)/miR-7 (high)/ITCH (low) | Derived from exons 6-13 of | TargetScan/TargetScanS, miRanda | Li F. et al., | |
| Cardiac fibrosis | CircHIPK3 (high)/miR-29b-3p (low)/a-SMA, COL1A1, COL3A1 (high) | Derived from exon 2 of | regRNA2 | Ni et al., | |
| Alzheimer's disease (AD) | CircHDAC9 (low)/miR-138 (high)/Sirt1 (low) | Localized in cytoplasm | TargetScan 7.0, miRanda 3.3a, RegRNA 2.0 | Lu et al., | |
| CiRS-7 (low)/miR-7 (high)/UBE2A (low) | CiRS-7 is found to have more than 70 miR-7 binding sites | UBE2A is an autophagic protein involved in amyloid peptide clearance in AD, and miR-7 is known to suppress its expression. CiRS-7 sponges miR-7 and declines its effect on UBE2A expression | Lukiw, |